Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Outlook Therapeutics (OTLK) over the last 6 years, with Q3 2025 value amounting to 1.51%.

  • Outlook Therapeutics' Return on Invested Capital changed N/A to 1.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.51%, marking a year-over-year change of. This contributed to the annual value of 1.9% for FY2019, which is 10000.0% up from last year.
  • As of Q3 2025, Outlook Therapeutics' Return on Invested Capital stood at 1.51%.
  • Outlook Therapeutics' Return on Invested Capital's 5-year high stood at 1.51% during Q3 2025, with a 5-year trough of 0.85% in Q1 2025.